[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-355156-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-355156-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","identification-and-characterization-of-marco-expressing-tumor-associated-macrophages-in-pancreatic-ductal-adenocarcinoma-with-pan-cancer-relevance","Identiﬁcation and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance","","Pancreatic ductal adenocarcinoma (PDAC) remains highly lethal, and immune checkpoint therapies often show limited effectiveness due to low immunogenicity and strong immunosuppression in the tumor microenvironment. This study investigates MARCO, a scavenger receptor class-A protein on macrophages. The work identifies a MARCO-expressing macrophage subset with strong immunosuppressive signatures enriched in PDAC, demonstrates VEGF-driven MARCO induction, and shows that Marco loss suppresses tumor growth in a murine PDAC model, with evidence for broader pan-cancer relevance.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/identification-and-characterization-of-marco-expressing-tumor-associated-macrophages-in-pancreatic-ductal-adenocarcinoma-with-pan-cancer-relevance/355156/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/identification-and-characterization-of-marco-expressing-tumor-associated-macrophages-in-pancreatic-ductal-adenocarcinoma-with-pan-cancer-relevance/355156.png","ImageObject",300,407,{"name":42,"@type":43},"Theodore","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",6,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What is MARCO and why is it studied in PDAC?","Question",{"text":63,"@type":64},"MARCO is a macrophage surface scavenger receptor. Its role in PDAC progression is investigated because MARCO-expressing macrophages may influence immune suppression and tumor growth.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How are MARCO-expressing macrophages linked to the PDAC immune landscape?",{"text":68,"@type":64},"MARCOhi PDAC samples show reduced CD8+ T cells and NK cells, alongside increased regulatory T cells, indicating a shift toward immunosuppression.",{"name":70,"@type":61,"acceptedAnswer":71},"What experimental evidence supports MARCO as a driver of PDAC progression?",{"text":72,"@type":64},"Co-culture and VEGF stimulation upregulate MARCO expression in macrophages. Genetic ablation of Marco suppresses tumor growth in a murine PDAC model, accompanied by increased NK and T cell proportions.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},355156,1790535863,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,105,110,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":102,"show_sort_weight":103,"slug":104},"Technology",50,"technology",{"id":106,"doc_module":4,"doc_module_name":25,"category_name":107,"show_sort_weight":108,"slug":109},7,"Healthcare",40,"healthcare",{"id":111,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},8,30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":111,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","npj | precision oncology Article  \n\n| Published in partnership with The Hormel Institute, University of Minnesota |  | |\n| --- | --- | --- |\n| [https://doi.org/10.1038/s41698-026-01293-5](https://doi.org/10.1038/s41698-026-01293-5) |  |  |\n| Identiﬁcation and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductaladenocarcinoma with pan-cancer relevance\u003Cbr> Check for updates |  |  |\n| Hao Sun1,2,12, Mengya Gao1,12, Zexing Liu1,12, Zhen Zhang3,12, Xudong Li4, Hong Huang5, Tiandong Li6, Jianxiang Shi7, Jiaqin Yan8, Mingxia Sun9, Miao Liu1, Yu An5, Siyue Li5, Yupeng Liu5, Zhenghua Huang5, Yuhan Hu5, Yuxuan Liu5, Chaoge Li5, Mengmeng Liu1, Meimei Yan1, Junfeng Chu10, Yongping Song5, Jinxin Miao11, Mengjia Li5, Zhilei Bian5, Wei Li5, Gangcheng Wang3 , Binglei Zhang5 , Shiyu Zuo5  & Linping Xu1  |  |  |\n| Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest cancers worldwide. The role of macrophage receptor with collagenous structure (MARCO), a scavenger receptor class-A protein expressed on macrophage surface, in PDAC progression remains unclear. Here, weidentiﬁeda subset of MARCO-expressing macrophages with strong immunosuppressive signatures that were markedly increased in PDAC patients. Analysis of MARCOhi PDAC samples displayed reduced proportion of CD8⁺ T cells and NK cells, accompanied by an increased proportion of regulatory T cells (Tregs) . In vitro, co-culture with multiple PDAC cell lines potently induced MARCO expression on both human and murine macrophages, driving them to a pro-tumorigenic polarization phenotype. Cell-cell interaction analyses further indicated that vascular endothelial growth factor(VEGF)selectively targets MARCO⁺ macrophages, and VEGF stimulation signiﬁcantly upregulates MARCO expression in vitro. Notably, genetic ablation of Marco markedly suppressed tumor growth in a murine PDAC model, at least partly through enhanced proportion of NK and T cells. Furthermore, MARCO⁺ macrophages were also enriched across several other cancer types, suggesting a potential pan-cancer relevance. Collectively, our ﬁndings uncover a critical role of MARCO⁺ macrophages in PDAC progression and highlight MARCO as a promising therapeutic target with potential applicability across multiple malignancies. |  |  |\n| Pancreatic ductaladenocarcinoma(PDAC), often referred toasthe “king of cancers”, is one of the cancers with the worst prognosis1,2. Recent epidemiological data show that the global incidence and mortality of this disease are steadily increasing, with a growing impact on younger populations, making it a major threat to public health3. Despite advances in surgery, chemotherapy, and radiotherapy, PDAC remains highly lethal, with a 5-year survival ofjust3%in metastatic cases4,5. In addition, immunotherapy | against PDAC produces a limited response due to low immunogenicity, high immunosuppression and dense desmoplastic stroma in the PDAC tumor microenvironment (TME)6. By contrast, successful inﬁltration and activation of T cells in the TME is associated with exceptional long-term survival in patients7. Thus, exploring strategies to modulate immune cell inﬁltration and activation in the PDAC TME may be key to improving patient prognosis. |  |\n\nA full list of afﬁliations appears at the end of the paper. e-mail: [gangcheng07@hotmail.com](gangcheng07@hotmail.com);  \n[zhangbinglei@zzu.edu.cn](zhangbinglei@zzu.edu.cn); [zuoshiyu0826@zzu.edu.cn](zuoshiyu0826@zzu.edu.cn); [zlyyxulinping1475@zzu.edu.cn](zlyyxulinping1475@zzu.edu.cn)  \nMacrophages represent a major component of tumor-inﬁltrating immune cells, and depending on activation signals, macrophages can acquire a spectrum of phenotypic states8. Tumor-associated macrophages (TAMs), key early inﬁltrators in the PDAC TME, critically regulate tumor progression, metastasis, immune modulation, angiogenesis, and responses to chemo-and immunotherapy9. Single-cell RNA sequencing (scRNA-seq) and spatial genomics increasingly uncover the co","cbCaijfoF1JifN4q","https://ap.wps.com/l/cbCaijfoF1JifN4q","pdf",5168142,17,"English","# Introduction\n## PDAC challenges and immune suppression\n## Macrophage biology and TAM heterogeneity\n## MARCO in cancer and antitumor immunity\n# Results (as described in provided text)\n## Identification of a MARCO+ macrophage subtype in PDAC\n## MARCO enrichment and prognostic relevance\n## scRNA-seq signatures and immune suppression\n## VEGF-mediated induction of MARCO\n## Marco genetic ablation and tumor growth effects","[{\"question\":\"What is MARCO and why is it studied in PDAC?\",\"answer\":\"MARCO is a macrophage surface scavenger receptor. Its role in PDAC progression is investigated because MARCO-expressing macrophages may influence immune suppression and tumor growth.\"},{\"question\":\"How are MARCO-expressing macrophages linked to the PDAC immune landscape?\",\"answer\":\"MARCOhi PDAC samples show reduced CD8+ T cells and NK cells, alongside increased regulatory T cells, indicating a shift toward immunosuppression.\"},{\"question\":\"What experimental evidence supports MARCO as a driver of PDAC progression?\",\"answer\":\"Co-culture and VEGF stimulation upregulate MARCO expression in macrophages. Genetic ablation of Marco suppresses tumor growth in a murine PDAC model, accompanied by increased NK and T cell proportions.\"}]","Identiﬁcation and characterization of MARCO-expressing tumor-associated macrophages in pancreatic ductal adenocarcinoma with pan-cancer relevance | PDF",1790116375,43,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/a3d8319f0a2e1e04eed0a86ee09a3330.webp",983,1305,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/326f0a9a7597fa3503c3d8081397f746.webp",982,1304,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/95514cda8190b46a463613080d5af722.webp",981,1303,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/91538640156ccd8b8dc7682ef56c77ae.webp",980,1301]